Microbiology automation company LBT Innovations has sold five APAS Independence laboratory instruments to pharmaceutical manufacturer AstraZeneca AB and will provide maintenance and support services over seven years. The total contract value is worth up to $4.1 million depending on the level of services required, and is in addition to the lease of a sixth instrument…
Laboratory automation manufacturer LBT Innovations has announced that its APAS PharmaQC automated pharmaceutical manufacturing quality control system was now commercially ready after an extensive period of R&D. Primary validation of the device has been completed and the technology formally released to pharmaceutical manufacturer AstraZeneca, a partner in the development. APAS PharmaQC provides automated imaging, analysis…
Energy Price Relief Plan aids manufacturers – claim The federal government claims it is delivering on cheaper energy for Australian manufacturers, with new figures showing a 1.5 percent decrease instead of the forecast 32.9 percent increase in energy prices. The figure was released by the government the day after the latest Australian Energy Market Operator…
